Summary
ATR Chart
CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR
PRINCETON, N.J. , July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions in the intensive care unit and cardiac surgery, today provided a regulatory update on its marketing applications for DrugSorb™-ATR with the U.S. Food and Drug Administration (FDA) and Health Canada.
CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR
PRINCETON, N.J. , June 24, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced that on June 18, 2025, it filed a request for supervisory review (administrative appeal) with the U.S. Food and Drug Administration (FDA) under 21 CFR 10.75, of the De Novo Denial Letter issued on April 25, 2025 for CytoSorbents' DrugSorb-ATR Device, (the denial letter).
AptarGroup (ATR) Upgraded to Strong Buy: Here's Why
AptarGroup (ATR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Atrem S.A. Dividends
 ATR 9 months ago | Other | zł0.49 Per Share |
| ATR 11 Aug 2023 | Other | zł0.11 Per Share |
| ATR 12 Sep 2022 | Other | zł0.66 Per Share |
| ATR 29 Jun 2016 | Other | zł0.05 Per Share |
| ATR 29 Jun 2015 | Other | zł0.08 Per Share |
Atrem S.A. Earnings
| 23 Mar 2024 Date | | - Cons. EPS | 0.54 EPS |
| 24 Nov 2023 Date | | - Cons. EPS | 0.11 EPS |
| 10 Nov 2016 Date | | - Cons. EPS | - EPS |
| 26 Aug 2016 Date | | - Cons. EPS | - EPS |
| 31 Mar 2016 Date | | - Cons. EPS | - EPS |
| ATR 9 months ago | Other | zł0.49 Per Share |
| ATR 11 Aug 2023 | Other | zł0.11 Per Share |
| ATR 12 Sep 2022 | Other | zł0.66 Per Share |
| ATR 29 Jun 2016 | Other | zł0.05 Per Share |
| ATR 29 Jun 2015 | Other | zł0.08 Per Share |
| 23 Mar 2024 Date | | - Cons. EPS | 0.54 EPS |
| 24 Nov 2023 Date | | - Cons. EPS | 0.11 EPS |
| 10 Nov 2016 Date | | - Cons. EPS | - EPS |
| 26 Aug 2016 Date | | - Cons. EPS | - EPS |
| 31 Mar 2016 Date | | - Cons. EPS | - EPS |
Atrem S.A. (ATR) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Atrem S.A. ever had a stock split?
Atrem S.A. Profile
| Medical - Instruments & Supplies Industry | Healthcare Sector | Stephan B. Tanda CEO | WSE Exchange | PLATREM00017 ISIN |
| US Country | 13,000 Employees | 5 Feb 2025 Last Dividend | 10 May 2007 Last Split | 21 Apr 1993 IPO Date |
Overview
AptarGroup, Inc. is at the forefront of designing and manufacturing innovative solutions for drug delivery, consumer product dispensing, and active material science. With a diverse portfolio aimed at meeting the needs of various markets such as pharmaceuticals, beauty, personal care, home care, and food and beverage, AptarGroup emphasizes its commitment to addressing consumer demands and industry challenges. Operating through three primary segments - Aptar Pharma, Aptar Beauty, and Aptar Closures, the company showcases a multifaceted approach to delivering excellence and innovation. Since its incorporation in 1992, AptarGroup has established a significant global presence, actively serving customers across Asia, Europe, Latin America, and North America from its headquarters in Crystal Lake, Illinois. This extensive footprint underscores its dedication to accessibility and service excellence worldwide.
Products and Services
The comprehensive range of products and services offered by AptarGroup caters to a wide array of market needs, ensuring high-quality, innovative solutions that enhance user experience and functionality. Here's a closer look at their offerings:
- Pumps for Nasal Allergy Treatments: AptarGroup has developed specialized dispensing pumps designed for the efficient and effective delivery of medication for nasal allergy relief. These products emphasize precision, ease of use, and improved patient compliance.
- Metered Dose Inhaler Valves: Targeted towards individuals with respiratory ailments such as asthma and chronic obstructive pulmonary diseases (COPD), these valves are a critical component in metered dose inhalers, facilitating accurate medication delivery and supporting better respiratory health management.
- Elastomer for Injectable Primary Packaging Components: AptarGroup's elastomeric components are essential for ensuring the safety, integrity, and effectiveness of injectable medications. These high-quality components play a crucial role in the pharmaceutical packaging industry.
- Active Material Science Solutions: Expanding beyond traditional dispensing solutions, AptarGroup is also deeply involved in offering active material science solutions. These innovations focus on enhancing product preservation, extending shelf life, and improving the overall consumer experience.
- Dispensing Pumps, Closures, and Aerosol Valves: AptarGroup’s product range includes a variety of dispensing pumps, closures, and aerosol valves designed for the consumer goods sector. These solutions are tailored to enhance the functionality and user-friendliness of a wide range of products, from personal care items to home cleaning agents.
- Digital Health Solutions: Recognizing the growing importance of technology in healthcare, AptarGroup offers digital health solutions that leverage the power of digital tools to enhance medication adherence, patient engagement, and overall health outcomes.
Contact Information
